PHARMACIELO LTD. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against PharmaCielo Ltd.   

LEAD PLAINTIFF DEADLINE IS MAY 5, 2020

NEW YORK, March 18, 2020 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP  announces that a federal securities class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of purchasers of the securities of PharmaCielo Ltd. (OTC: PCLOF) between June 21, 2019 and March 2, 2020, inclusive (the "Class Period").

All   investors who purchased shares of PharmaCielo Ltd. and incurred losses are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action or join the case on our website, www.whafh.com.

If you have incurred losses in the shares of PharmaCielo Ltd., you may, no later than May 11, 2020, request that the Court appoint you lead plaintiff of the proposed class. Please contact Wolf Haldenstein to learn more about your rights as an investor in the shares of PharmaCielo Ltd.

## Follow the firm and learn about newly filed cases on Twitter and Facebook ##

CLICK HERE TO JOIN THE CASE 

According to the filed complaint, defendants throughout the Class Period made false
and/or misleading statements and/or failed to disclose that:

• PharmaCielo engaged in an undisclosed related party transactions with General Extract LLC;
   
• PharmaCielo engaged in misleading transactions and loans with General Extract LLC and XPhyto Therapeutics Corp.;
   
• PharmaCielo's Research Technology and Processing Centre was never on-schedule and is delayed;
   
• The Rionegro facility is located on a floodplain and contaminated with mold and
  pesticides from its previous tenants;
   
• PharmaCielo's Cauca Department land has never been utilized by the Company and is idle; and
   
• As  a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country.  The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego.  The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.

If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at [email protected], or visit our website at  www.whafh.com.

Contact:

Wolf Haldenstein Adler Freeman & Herz LLP
Kevin Cooper, Esq.
Gregory Stone, Director of Case and Financial Analysis
Email: [email protected], [email protected] or [email protected]
Tel: (800) 575-0735 or (212) 545-4774

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.